Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Current Medical Research and Opinion

Volumn 26, Issue 9, 2010, Pages 2193-2202

  Ferrieres, Jean ^a   Bakhai, Ameet ^b,c   Iñiguez, Andres ^d   Schmitt, Claude ^e   Sartral, Magali ^e   Belger, Mark ^e   Zeymer, Uwe ^f  

^a CHU RANGUEIL   (France)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c AMORE Health Ltd   (United Kingdom)

^d HOSPITAL DO MEIXOEIRO   (Spain)

^e ELI LILLY AND COMPANY   (United States)

^f Institut Fr Herzinfarktforschung   (Germany)

Author keywords

Acute coronary syndrome; Antiplatelet therapy; Bare metal stent; Clinical outcomes; Drug eluting stent; Percutaneous coronary intervention

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY STENT; DEATH; DRUG ELUTING STENT; FEMALE; FRANCE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; SPAIN; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; UNITED KINGDOM; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; FEMALE; FRANCE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROFESSIONAL PRACTICE; REGISTRIES; SPAIN; TREATMENT OUTCOME;

EID: 77955616896     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.509257     Document Type: Article

References (19)

1. Taylor MJ, Scuffham PA, McCollam PL, et al. Acute coronary syndromes in Europe: 1-year costs and outcomes. Current medical research and opinion 2007;23:495-503
2. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007;116:e148-304
3. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008;117:296-329
4. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-1660
5. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-2945
6. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847 (Pubitemid 40547082)
7. Bauer T, Koeth O, Junger C, et al. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. Eur Heart J 2007;28:2873-2878
8. Lim MJ, Spencer FA, Gore JM, et al. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-STsegment elevation acute coronary syndromes: perspectives from a large multinational registry. Eur Heart J 2005;26:1063-1069
9. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002;90:358-363
10. Taneja AK, Collinson J, Flather MD, et al. Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK). Eur Heart J 2004;25:2013-2018
11. Zeymer U, Gitt AK, Junger C, et al. Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice. Eur Heart J 2006;27:2661-2666
12. Zeymer U, Vogt A, Zahn R, et al. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 2004; 25:322-328
13. Jolly SS, Pogue J, Haladyn K, et al. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study. Eur Heart J 2009;30:900-907
14. Montalescot G, Sideris G, Meuleman C, et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 2006;48:931-938
15. Danchin N, Blanchard D, Chevalier B, et al. Use of drug eluting stents: expert consensus of the French Society of Cardiology. Arch Cardiovasc Dis 2008;101:190-193
16. Baz JA, Pinar E, Albarran A, et al. Spanish Cardiac Catheterization and Coronary Intervention Registry. 17th official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2007). Rev Esp Cardiol 2008;61:1298-1314
17. Ludman PF. British Cardiovascular Intervention Society audit returns. Adult Interventional Procedures. Presented in Crewe, UK, 2008
18. Morrow DA, Wiviott SD, White HD, et al. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation 2009; 119:2758-2764
19. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-1206